Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

9.6%

5 terminated/withdrawn out of 52 trials

Success Rate

80.8%

-5.7% vs industry average

Late-Stage Pipeline

23%

12 trials in Phase 3/4

Results Transparency

5%

1 of 21 completed trials have results

Key Signals

7 recruiting1 with results

Enrollment Performance

Analytics

N/A
24(61.5%)
Phase 4
6(15.4%)
Phase 3
6(15.4%)
Phase 2
3(7.7%)
39Total
N/A(24)
Phase 4(6)
Phase 3(6)
Phase 2(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (52)

Showing 20 of 52 trials
NCT07188350Not ApplicableRecruiting

Neuromuscular Electrical Stimulation in a Patient on Invasive Mechanical Ventilation (MOVCARE)

Role: lead

NCT05343936Active Not Recruiting

Evaluation of an Active Surveillance Protocol for Prostate Cancer in the Brazilian Population

Role: lead

NCT05306600Recruiting

Onco-Genomas Brasil: Mapping Breast and Prostate Cancer in the Brazilian Public Health System

Role: lead

NCT05673226Not ApplicableCompleted

Organosilane for Surface Cleaning in Intensive Care Units

Role: collaborator

NCT07186517Not Yet Recruiting

Genetic Variants in Stroke

Role: lead

NCT05266066Not ApplicableRecruiting

Ventilator-associated Tracheobronchitis Initiative to Conduct Antibiotic Evaluation

Role: collaborator

NCT05572736Not ApplicableCompleted

Conduction System Pacing Versus Biventricular Resynchronization in Patients With Chronic Heart Failure

Role: lead

NCT05199194Phase 3Recruiting

Randomization to Endovascular Treatment Alone or Preceded by Systemic Thrombolysis With Tenecteplase in Ischemic Stroke

Role: lead

NCT05199662Phase 3Recruiting

Randomization to Extend Stroke Intravenous ThromboLysis In Evolving Non-Large Vessel Occlusion With TNK (RESILIENT

Role: lead

NCT06903260Phase 3Completed

Robot-assisted Partial Nephrectomy With and Without Mixed Reality (REALITATEM Study)

Role: lead

NCT05155137Phase 3Recruiting

Polypill and RiscOMeter to Prevent StrOke and CogniTive ImpairmEnt (PROMOTE)

Role: lead

NCT05485051Phase 3Completed

Daily Chlorexidine Bath for Health Care Associated Infection Prevention

Role: collaborator

NCT06365528Not ApplicableRecruiting

Tunneled Peripherally Inserted Central Catheter (PICC) in Adult Patients and Associated Outcomes

Role: collaborator

NCT05210387Not ApplicableTerminated

Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections

Role: lead

NCT04410107Completed

Lung Function, Exercise Capacity and Health-Related Quality of Life After Severe COVID-19

Role: collaborator

NCT05197647Unknown

Cohort Study for the Assessment of Long-term Impact of COVID-19 Among Mild COVID-19 Patients in Brazil

Role: lead

NCT05403307Completed

A Real-world Evidence Study of BNT162b2 mRNA Covid-19 Vaccine Among Children in Brazil

Role: lead

NCT05052307Completed

A Real-world Evidence Study of BNT162b2 mRNA Covid-19 Vaccine in Brazil

Role: lead

NCT05165979Unknown

Cohort Study for the Assessment of Long-term Impact of COVID-19 Among Moderate and Severe COVID-19 Patients in Brazil

Role: lead

NCT05249309Unknown

Naturalistic Study of Ketamine in the Treatment of Depression

Role: collaborator